A detailed history of Genesis Private Wealth, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Genesis Private Wealth, LLC holds 549 shares of LLY stock, worth $560,913. This represents 0.18% of its overall portfolio holdings.

Number of Shares
549
Previous 304 80.59%
Holding current value
$560,913
Previous $232 Million 154.36%
% of portfolio
0.18%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 08, 2026

BUY
$799.57 - $1025.28 $195,894 - $251,193
245 Added 80.59%
549 $590 Million
Q3 2025

Oct 08, 2025

SELL
$625.65 - $812.69 $35,036 - $45,510
-56 Reduced 15.56%
304 $232 Million
Q2 2025

Jul 17, 2025

BUY
$713.71 - $898.95 $14,274 - $17,979
20 Added 5.88%
360 $281 Million
Q1 2025

Apr 23, 2025

BUY
$725.72 - $929.72 $26,125 - $33,469
36 Added 11.84%
340 $281 Million
Q4 2024

Jan 17, 2025

BUY
$727.2 - $932.06 $221,068 - $283,346
304 New
304 $235 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Genesis Private Wealth, LLC Portfolio

Follow Genesis Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Genesis Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Genesis Private Wealth, LLC with notifications on news.